Cargando…

Patient-derived organoids for therapy personalization in inflammatory bowel diseases

Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders of the intestinal tract that have emerged as a growing problem in industrialized countries. Knowledge of IBD pathogenesis is still incomplete, and the most widely-accepted interpretation considers genetic factors, environmental st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lucafò, Marianna, Muzzo, Antonella, Marcuzzi, Martina, Giorio, Lorenzo, Decorti, Giuliana, Stocco, Gabriele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260862/ https://www.ncbi.nlm.nih.gov/pubmed/35979165 http://dx.doi.org/10.3748/wjg.v28.i24.2636

Ejemplares similares

Microbiota and Drug Response in Inflammatory Bowel Disease
por: Franzin, Martina, et al.
Publicado: (2021)

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention
por: Lucafò, Marianna, et al.
Publicado: (2021)

Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease
por: Lucafò, Marianna, et al.
Publicado: (2021)

Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease
por: Di Silvestre, Alessia, et al.
Publicado: (2019)

Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease
por: Curci, Debora, et al.
Publicado: (2021)

Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease
por: Curci, Debora, et al.
Publicado: (2022)

Pharmacogenomics of Antibiotics
por: Stocco, Gabriele, et al.
Publicado: (2020)

Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events
por: Genova, Elena, et al.
Publicado: (2019)

Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease
por: Lucafò, Marianna, et al.
Publicado: (2021)

Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients
por: Lucafò, Marianna, et al.
Publicado: (2019)

A Validated HPLC–Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside
por: Franzin, Martina, et al.
Publicado: (2022)

Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants
por: Lucafò, Marianna, et al.
Publicado: (2019)

Pharmacogenetics of thiopurines
por: Franca, Raffaella, et al.
Publicado: (2019)

High-Throughput Sequencing of microRNAs in Glucocorticoid Sensitive Paediatric Inflammatory Bowel Disease Patients
por: De Iudicibus, Sara, et al.
Publicado: (2018)

Long Non-Coding RNA GAS5 and Intestinal MMP2 and MMP9 Expression: A Translational Study in Pediatric Patients with IBD
por: Lucafò, Marianna, et al.
Publicado: (2019)

PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells
por: Zudeh, Giulia, et al.
Publicado: (2023)

Expression Pattern of Long Non-coding RNA Growth Arrest-specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia
por: Gasic, Vladimir, et al.
Publicado: (2019)

Biomarkers for gastrointestinal adverse events related to thiopurine therapy
por: Zudeh, Giulia, et al.
Publicado: (2021)

Induced pluripotent stem cells as an innovative model to study drug induced pancreatitis
por: Genova, Elena, et al.
Publicado: (2021)

Multilocus Genotypes of Relevance for Drug Metabolizing Enzymes and Therapy with Thiopurines in Patients with Acute Lymphoblastic Leukemia
por: Stocco, Gabriele, et al.
Publicado: (2013)

miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway
por: Lucafò, Marianna, et al.
Publicado: (2020)

5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis
por: Pastore, Serena, et al.
Publicado: (2014)

A new proof of evidence of cysteamine quantification for therapeutic drug monitoring in patients with cystinosis
por: Franzin, Martina, et al.
Publicado: (2022)

Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid‐resistant from glucocorticoid‐sensitive idiopathic nephrotic syndrome patients
por: Lucafò, Marianna, et al.
Publicado: (2021)

Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children
por: Franca, Raffaella, et al.
Publicado: (2015)

In Vitro Effects of Sulforaphane on Interferon-Driven Inflammation and Exploratory Evaluation in Two Healthy Volunteers
por: Genova, Elena, et al.
Publicado: (2021)

Organoid-based regenerative medicine for inflammatory bowel disease
por: Okamoto, Ryuichi, et al.
Publicado: (2020)

Curcumin and Inflammatory Bowel Disease: Potential and Limits of Innovative Treatments
por: Vecchi Brumatti, Liza, et al.
Publicado: (2014)

Potential Use of Human Stem Cell–Derived Intestinal Organoids to Study Inflammatory Bowel Diseases
por: Dotti, Isabella, et al.
Publicado: (2018)

Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research
por: Angus, Hamish C. K., et al.
Publicado: (2020)

Quantification of 7 cannabinoids in cannabis oil using GC-MS: Method development, validation and application to therapeutic preparations in Friuli Venezia Giulia region, Italy
por: Franzin, Martina, et al.
Publicado: (2023)

Characterization of Human Colon Organoids From Inflammatory Bowel Disease Patients
por: d’Aldebert, Emilie, et al.
Publicado: (2020)

The Role of Organoids as a Novel Platform for Modeling of Inflammatory Bowel Disease
por: O'Connell, Lauren, et al.
Publicado: (2021)

Patient‐derived renal cell carcinoma organoids for personalized cancer therapy
por: Li, Zhichao, et al.
Publicado: (2022)

Advances of Patient-Derived Organoids in Personalized Radiotherapy
por: Wang, Yuenan, et al.
Publicado: (2022)

Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases
por: Papamichael, Konstantinos, et al.
Publicado: (2023)

Intestinal Organoids as a Novel Complementary Model to Dissect Inflammatory Bowel Disease
por: Schulte, L., et al.
Publicado: (2019)

Generation of human colon organoids from healthy and inflammatory bowel disease mucosa
por: Dotti, Isabella, et al.
Publicado: (2022)

Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma
por: Ratliff, Miriam, et al.
Publicado: (2022)

Validating organoid-derived human intestinal monolayers for personalized therapy in cystic fibrosis
por: Birimberg-Schwartz, Liron, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lo4eg129el0221qrejcsj17o8i